Clinical trials
Observational End Stage Liver Disease trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2019 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Suspended | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arbor Research Collaborative for Health | 2 |
| Centre hospitalier de l'Université de Montréal (CHUM) | 2 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| End Stage Liver Disease | 6 |
| Liver Diseases | 2 |
| Cholestasis | 1 |
| Fatty Liver | 1 |
| Fibrosis | 1 |
| Hepatitis C | 1 |
| Liver Cirrhosis | 1 |
| Liver Failure, Acute | 1 |
| Liver Neoplasms | 1 |
| Mitochondrial Diseases | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.